2024 Satellite Symposia
Satellite Symposia Schedule
Thank you for registering for the 2024 Crohn’s & Colitis Congress®. While you’re at the Congress, you can take advantage of any of the following satellite symposia. Please be sure to register for each one separately.
Navigating the New Treatment Landscape for Inflammatory Bowel Disease
Thursday, January 19, 7:00–8:30 p.m.
In partnership with Medscape. Supported by an educational grant from AbbVie.
- Russell D. Cohen, MD, AGAF
- Ryan C. Ungaro, MD, MS
- Sandra Quezada, MD, MS, AGAF
Upon completion of this activity, participants will:
- Have increased knowledge regarding the:
- Mechanisms of action of newer targeted treatments for IBD.
- Clinical data on newer targeted IBD treatments.
- Have greater competence related to:
- Recommending evidence-based IBD treatments that consider patients’ comorbid conditions.
- Utilizing appropriate laboratory monitoring prior to and during treatment with newer targeted IBD agents.
- Greater confidence in their ability to
- Incorporate new targeted agents for IBD into treatment strategies
What They Say and What They Think: Exploring Tools for Assessing Bowel Urgency in Patients with Ulcerative Colitis
Friday, January 20, 6:00–7:30 a.m.
In partnership with PeerVoice. Supported by an educational grant from Lilly.
- David T. Rubin, MD, AGAF
- Marla C. Dubinsky, MD
- Adam Benjamin, MD – patient advocate
As a result of this activity, learners should be able to:
- Discuss latest evidence on bowel urgency in patients with ulcerative colitis (UC) and its influence on quality of life.
- Analyze current communication gaps between patients with UC and clinicians during clinic visits.
- Recognize the benefits and limitations of current patient-reported outcomes tools.
Back to Basics – Examining Mechanisms of New IBD Therapies
Friday, January 20, 12:15–1:45 p.m.
In partnership with CME Outfitters, LLC. Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
- Marla Dubinsky, MD – moderator
- Sara Horst, MD, MPH
- Gil Y. Melmed, MD, MS, AGAF
- Incorporate evidence-based clinical, biomarker, and endoscopic treatment targets into clinical practice when developing treatment goals for patients with IBD.
- Develop treatment plans based on comparative efficacy and safety data for biologic-naïve and biologic-experienced patients with IBD.
- Engage an interprofessional team to improve patient care and IBD treatment outcomes.
The Crohn’s & Colitis Congress® will offer four live, in-person symposia slots. Satellite symposia slots will be filled on a first-come, first-served basis via an online application. The online application will be available until December 1, 2023. All symposiums will occur during breakfast or lunch times.
|Thursday, Jan. 25||5:00–6:30 p.m.||Lilly USA|
|Friday, Jan. 26||6:00–7:30 a.m.||Available|
|Friday, Jan. 26||12:30–2:00 p.m.||Janssen Biotech, Inc.|
|Saturday, Jan. 27||6:00–7:30 a.m.||Available|